(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CYLEMBIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CYLEMBIO

ST13

US500000098394978

Class

5

Filing

98394978

Registration

7676178

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

02/04/2025

Trademark type

Combined

Nice classes

5

Filing date

02/06/2024

Registration date

02/04/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/04/2025

Last transaction

02/04/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

99

Owner location

Copenhagen N, DK

Examiner

THOMAS, JULIE

Law office

L70

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording CYLEMBIO with a circle made up of ten circles of varying sizes in a circular pattern above the letter "I".

Holders and representatives

Holders

I. A. (pessoa física)

Representatives

Bryce J. Maynard BUCHANAN INGERSOLL & ROONEY PC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the prevention and treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricinfection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricinfection and immune system related diseases; vaccines

Publications

History of USPTO decisions and trademark events.

17 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/17/2024

PUBO

PUBLISHED FOR OPPOSITION

12/17/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

10/17/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/07/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/02/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/02/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/02/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/11/2024

GNRT

NON-FINAL ACTION E-MAILED

09/11/2024

CNRT

NON-FINAL ACTION WRITTEN

09/11/2024

DOCK

ASSIGNED TO EXAMINER

08/29/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/15/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/14/2024

NWAP

NEW APPLICATION ENTERED

02/09/2024

Continuous trademark protection

Get notified about every new filing that threatens CYLEMBIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.